Indian vaccine majors Serum Institute of India and Bharat Biotech on Saturday announced reduction of prices of their vaccines' precaution doses to Rs 225.
They said the decision was taken in consultation with the Indian government.
We are pleased to announce that after discussion with the Central Government, SII has decided to revise the price of COVISHIELD vaccine for private hospitals from Rs.600 to Rs 225 per dose. We once again commend this decision from the Centre to open precautionary dose to all 18+.— Adar Poonawalla (@adarpoonawalla) April 9, 2022
The Serum Institute on Friday said that the precaution dose of its Covishield vaccine will be priced at Rs 600 per jab.
The earlier price of Covaxin was Rs 1,200.
Announcing #CovaxinPricing .— Suchitra Ella (@SuchitraElla) April 9, 2022
We welcome the decision to make available precautionary dose for all adults. In consultation with the Central Government, we have decided to revise the price of #COVAXIN from Rs 1200 to Rs 225 per dose, for #privatehospitals.🇮🇳💉💉💉😷
The Union health ministry on Friday announced that those above the age of 18 years who have completed nine months after the administration of the second dose will be eligible for the precaution dose.
The Serum Institute and Bharat Biotech have been major suppliers of COVID-19 vaccines to the Indian government so far.
Around 96 per cent of all those above 15 years of age in India have so far received at least one vaccine dose, while around 83 per cent have received both doses, according to the Union health ministry
More than 2.4 crore precaution doses have also been administered to healthcare workers, frontline workers, and those aged above 60 years. Besides, 45 per cent of beneficiaries in the 12-14 years age group have received the first dose, according to the Union health ministry.
The ministry further said the ongoing free COVID-19 vaccination programme through government centres for first and second doses to the eligible population as well as the precaution dose to healthcare workers, frontline workers, and those above 60 years will be accelerated.
With PTI inputs